Search - tctmd.com

Displaying 221 - 240 of 8325

Sort: Relevancy | Date

Presentation TCT 2016

IMPACT: Randomized Evaluation of a Rapid Exchange FFR Microcatheter in Intermediate Coronary Stenoses

Presenter: Bernard De Bruyne, Allen Jeremias, Tim P. van de Hoef

November 01, 2016

Presentation TCT 2016

FDA Perspectives on Short DAPT IDE Trials

Presenter: Michael C. John, Gregg W. Stone, Andrew Farb

November 01, 2016

Presentation TCT 2016

What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT

Presenter: David P. Faxon, C. Michael Gibson, Freek W.A. Verheugt

November 01, 2016

Presentation TCT 2016

BRS Benchtop Findings: Implications for Implantation Techniques

Presenter: Stephen G. Ellis, Patrick W. Serruys, Nicolas Foin

November 01, 2016

Presentation TCT 2016

Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS

Presenter: Philip M. Urban, Stephen G. Worthley, Sigmund Silber

November 01, 2016

Presentation TCT 2016

FDA Regulatory Considerations for Novel and Not-So-Novel New Metallic DES and Bioresorbable Scaffolds

Presenter: Michael C. John, Gregg W. Stone, P.F. Adrian Magee

November 01, 2016

Presentation TCT 2016

Impact of Different PLLA Polymers and BRS Construction on Implant Technique: From Absorb to DESolve to Fantom to Manli and More

Presenter: Stephen G. Ellis, Patrick W. Serruys, Alexandre Abizaid

November 01, 2016

Presentation TCT 2016

Retrograde Step-by-step

Presenter: Alfredo R. Galassi, Masahiko Ochiai, James C. Spratt

November 01, 2016

Presentation TCT 2016

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus DAPT

Presenter: David P. Faxon, C. Michael Gibson, Christopher B. Granger

November 01, 2016

Presentation TCT 2016

Standard and Novel Pressure Measuring Devices: Differences, Similarities, and Practical Recommendations

Presenter: Bernard De Bruyne, Allen Jeremias, Morton J. Kern

November 01, 2016

Presentation TCT 2016

Novel DCB Coatings and Alternative Drugs: Are We Reaching the End of the Road?

Presenter: Fernando Alfonso, Juan F. Granada

November 01, 2016

Presentation TCT 2016

Complications Related to Contrast and Commonly Used Medications

Presenter: Giora Weisz, Payam Dehghani

November 01, 2016

Presentation TCT 2016

Case Resolution: What Was Done

Presenter: John A. Bittl, David J. Maron, Kishore J. Harjai

November 01, 2016

Presentation TCT 2016

Can CT Identify Vulnerable Plaque and Eventually Predict Myocardial Infarction?

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min

November 01, 2016

Presentation TCT 2016

The Case for Surgery

Presenter: Michael A. Borger, Vinod H. Thourani, Martin Misfeld

November 01, 2016

Presentation TCT 2016

Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD!

Presenter: Sanjay Kaul, Jeffrey J. Popma, John D. Puskas

November 01, 2016

Presentation TCT 2016

Debate: Should Complete Revascularization in STEMI and Multivessel Disease Be Performed During the Index Procedure? Yes, in Most Patients, to Improve Prognosis and Reduce Costs!

Presenter: Adrian P. Banning, Nick Curzen, Keith G. Oldroyd

November 01, 2016

Presentation TCT 2016

My Top Predictions for the Next Decade of Vulnerable Plaque Research: Insights From a Soothsayer

Presenter: Gregg W. Stone, Ron Waksman, John A. Ambrose

November 01, 2016

Presentation TCT 2016

When Equipoise Exists: Is Unbiased, Informed Consent Possible?

Presenter: John A. Bittl, David J. Maron, John A. Spertus

November 01, 2016

Presentation TCT 2016

Methods and Technologies to Improve DCB Outcomes: Does the Data Support Their Use?

Presenter: Fernando Alfonso, Juan F. Granada, Azeem Latib

November 01, 2016

Advertisement

IMPACT: Randomized Evaluation of a Rapid Exchange FFR Microcatheter in Intermediate Coronary Stenoses

FDA Perspectives on Short DAPT IDE Trials

What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT

BRS Benchtop Findings: Implications for Implantation Techniques

Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS

FDA Regulatory Considerations for Novel and Not-So-Novel New Metallic DES and Bioresorbable Scaffolds

Impact of Different PLLA Polymers and BRS Construction on Implant Technique: From Absorb to DESolve to Fantom to Manli and More

Retrograde Step-by-step

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus DAPT

Standard and Novel Pressure Measuring Devices: Differences, Similarities, and Practical Recommendations

Novel DCB Coatings and Alternative Drugs: Are We Reaching the End of the Road?

Complications Related to Contrast and Commonly Used Medications

Case Resolution: What Was Done

Can CT Identify Vulnerable Plaque and Eventually Predict Myocardial Infarction?

The Case for Surgery

Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD!

Debate: Should Complete Revascularization in STEMI and Multivessel Disease Be Performed During the Index Procedure? Yes, in Most Patients, to Improve Prognosis and Reduce Costs!

My Top Predictions for the Next Decade of Vulnerable Plaque Research: Insights From a Soothsayer

When Equipoise Exists: Is Unbiased, Informed Consent Possible?

Methods and Technologies to Improve DCB Outcomes: Does the Data Support Their Use?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content